A detailed history of Geode Capital Management, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 920,363 shares of AMPH stock, worth $32.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
920,363
Previous 906,348 1.55%
Holding current value
$32.4 Million
Previous $36.3 Million 23.2%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$36.99 - $50.09 $518,414 - $702,011
14,015 Added 1.55%
920,363 $44.7 Million
Q2 2024

Aug 09, 2024

BUY
$38.65 - $43.48 $1.56 Million - $1.75 Million
40,316 Added 4.66%
906,348 $36.3 Million
Q1 2024

May 13, 2024

BUY
$42.85 - $63.45 $830,433 - $1.23 Million
19,380 Added 2.29%
866,032 $38 Million
Q4 2023

Feb 13, 2024

BUY
$44.49 - $62.93 $1.65 Million - $2.33 Million
37,026 Added 4.57%
846,652 $52.4 Million
Q3 2023

Nov 13, 2023

BUY
$45.51 - $65.0 $1.34 Million - $1.91 Million
29,367 Added 3.76%
809,626 $37.2 Million
Q2 2023

Aug 11, 2023

BUY
$35.77 - $58.38 $725,344 - $1.18 Million
20,278 Added 2.67%
780,259 $44.8 Million
Q1 2023

May 15, 2023

BUY
$27.99 - $37.92 $1.06 Million - $1.43 Million
37,700 Added 5.22%
759,981 $28.5 Million
Q4 2022

Feb 13, 2023

BUY
$27.93 - $31.27 $393,114 - $440,125
14,075 Added 1.99%
722,281 $20.2 Million
Q3 2022

Nov 14, 2022

BUY
$27.56 - $37.75 $435,944 - $597,129
15,818 Added 2.28%
708,206 $19.9 Million
Q2 2022

Aug 12, 2022

SELL
$29.79 - $42.29 $330,400 - $469,038
-11,091 Reduced 1.58%
692,388 $24.1 Million
Q1 2022

May 13, 2022

SELL
$22.96 - $36.45 $261,606 - $415,311
-11,394 Reduced 1.59%
703,479 $25.3 Million
Q4 2021

Feb 11, 2022

BUY
$18.14 - $23.29 $198,778 - $255,211
10,958 Added 1.56%
714,873 $16.6 Million
Q3 2021

Nov 12, 2021

BUY
$17.83 - $21.49 $264,436 - $318,718
14,831 Added 2.15%
703,915 $13.4 Million
Q2 2021

Aug 13, 2021

BUY
$17.11 - $20.92 $490,560 - $599,797
28,671 Added 4.34%
689,084 $13.9 Million
Q1 2021

May 12, 2021

BUY
$17.21 - $20.65 $1.48 Million - $1.78 Million
86,269 Added 15.03%
660,413 $12.1 Million
Q4 2020

Feb 12, 2021

BUY
$17.76 - $21.24 $566,135 - $677,067
31,877 Added 5.88%
574,144 $11.5 Million
Q3 2020

Nov 13, 2020

BUY
$17.99 - $22.22 $31,428 - $38,818
1,747 Added 0.32%
542,267 $10.2 Million
Q2 2020

Aug 13, 2020

BUY
$14.25 - $22.46 $91,798 - $144,687
6,442 Added 1.21%
540,520 $12.1 Million
Q1 2020

May 14, 2020

BUY
$12.66 - $20.08 $370,305 - $587,340
29,250 Added 5.79%
534,078 $7.93 Million
Q4 2019

Feb 13, 2020

BUY
$17.07 - $20.64 $218,615 - $264,336
12,807 Added 2.6%
504,828 $9.74 Million
Q3 2019

Nov 12, 2019

BUY
$19.12 - $22.62 $149,308 - $176,639
7,809 Added 1.61%
492,021 $9.76 Million
Q2 2019

Aug 14, 2019

BUY
$18.92 - $22.96 $749,875 - $909,996
39,634 Added 8.91%
484,212 $10.2 Million
Q1 2019

May 14, 2019

BUY
$19.46 - $25.28 $375,130 - $487,322
19,277 Added 4.53%
444,578 $9.08 Million
Q4 2018

Feb 13, 2019

BUY
$17.72 - $22.51 $651,812 - $828,007
36,784 Added 9.47%
425,301 $8.46 Million
Q3 2018

Nov 13, 2018

BUY
$15.39 - $19.38 $117,856 - $148,412
7,658 Added 2.01%
388,517 $7.48 Million
Q2 2018

Aug 14, 2018

BUY
$14.63 - $19.6 $576,319 - $772,102
39,393 Added 11.54%
380,859 $5.81 Million
Q1 2018

May 15, 2018

BUY
$17.23 - $20.35 $148,901 - $175,864
8,642 Added 2.6%
341,466 $6.4 Million
Q4 2017

Feb 13, 2018

BUY
$17.76 - $19.75 $96,525 - $107,341
5,435 Added 1.66%
332,824 $6.4 Million
Q3 2017

Nov 14, 2017

BUY
$14.73 - $17.99 $123,113 - $150,360
8,358 Added 2.62%
327,389 $5.85 Million
Q2 2017

Aug 14, 2017

BUY
N/A
319,031
319,031 $5.7 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.73B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.